Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-24 08:56 am Unchanged |
2025-04-24 | 13D | ESSA Pharma Inc. EPIX |
BML Investment Partners, L.P. | 4,221,546 9.500% |
0 (Unchanged) |
Filing History |
| 2025-04-23 9:45 pm Unchanged |
2025-04-23 | 13D | ESSA Pharma Inc. EPIX |
SOLEUS CAPITAL MASTER FUND, L.P. | 2,262,026 5.100% |
0 (Unchanged) |
Filing History |
| 2025-04-15 4:46 pm Purchase |
2025-04-15 | 13D | ESSA Pharma Inc. EPIX |
SOLEUS CAPITAL MASTER FUND, L.P. | 2,262,026 5.100% |
2,262,026 (New Position) |
Filing History |
| 2025-04-09 09:00 am Unchanged |
2025-04-09 | 13D | ESSA Pharma Inc. EPIX |
BIOTECHNOLOGY VALUE FUND L P | 8,748,629 19.700% |
0 (Unchanged) |
Filing History |
| 2025-02-14 4:06 pm Sale |
2024-12-31 | 13G | ESSA Pharma Inc. EPIX |
PFM Health Sciences, LP | 0 0.000% |
-2,742,936 (Position Closed) |
Filing History |
| 2025-02-14 10:26 am Purchase |
2024-12-31 | 13G | ESSA Pharma Inc. EPIX |
BML Investment Partners, L.P. | 4,221,546 9.500% |
38,323 (+0.92%) |
Filing History |
| 2025-02-14 09:49 am Unchanged |
2024-12-31 | 13G | ESSA Pharma Inc. EPIX |
BML Investment Partners, L.P. | 4,183,223 9.400% |
0 (Unchanged) |
Filing History |
| 2025-02-14 09:00 am Sale |
2024-12-31 | 13G | ESSA Pharma Inc. EPIX |
RTW Investments, LP | 1,113,002 2.500% |
-2,148,494 (-65.87%) |
Filing History |
| 2025-02-11 4:00 pm Sale |
2024-12-31 | 13G | ESSA Pharma Inc. EPIX |
Soleus Capital Special Opportunities Fund, L.P. | 2,262,026 5.100% |
-2,065,596 (-47.73%) |
Filing History |
| 2024-11-14 7:32 pm Sale |
2024-11-01 | 13G | ESSA Pharma Inc. EPIX |
BB Biotech AG | 0 0.000% |
-7,879,583 (Position Closed) |
Filing History |
| 2024-11-14 4:04 pm Sale |
2024-09-30 | 13G | ESSA Pharma Inc. EPIX |
PFM Health Sciences, LP | 2,742,936 6.200% |
-519,564 (-15.93%) |
Filing History |
| 2024-11-14 06:56 am Purchase |
2024-09-30 | 13G | ESSA Pharma Inc. EPIX |
RTW Investments, LP | 3,261,496 7.400% |
962,834 (+41.89%) |
Filing History |
| 2024-11-08 4:56 pm Purchase |
2024-11-01 | 13D | ESSA Pharma Inc. EPIX |
TANG CAPITAL MANAGEMENT, LLC | 4,300,000 9.700% |
4,300,000 (New Position) |
Filing History |
| 2024-11-07 12:50 pm Purchase |
2024-11-01 | 13G | ESSA Pharma Inc. EPIX |
BML Investment Partners, L.P. | 4,183,223 9.400% |
4,183,223 (New Position) |
Filing History |
| 2024-02-14 4:06 pm Sale |
2023-12-31 | 13G | ESSA Pharma Inc. EPIX |
PFM Health Sciences, LP | 3,262,500 7.400% |
-581,832 (-15.13%) |
Filing History |
| 2024-02-14 07:05 am Purchase |
2023-12-31 | 13G | ESSA Pharma Inc. EPIX |
RTW Investments, LP | 2,298,662 5.200% |
2,298,662 (New Position) |
Filing History |
| 2024-02-13 06:04 am Unchanged |
2023-12-31 | 13G | ESSA Pharma Inc. EPIX |
BB Biotech AG | 7,879,583 17.900% |
0 (Unchanged) |
Filing History |
| 2024-02-08 11:29 am Purchase |
2023-12-31 | 13G | ESSA Pharma Inc. EPIX |
MORGAN STANLEY MS |
4,186,578 9.500% |
4,186,578 (New Position) |
Filing History |
| 2024-01-23 4:09 pm Purchase |
2023-12-31 | 13G | ESSA Pharma Inc. EPIX |
Soleus Capital Special Opportunities Fund, L.P. | 4,327,622 9.800% |
458,230 (+11.84%) |
Filing History |
| 2023-02-14 4:12 pm Purchase |
2022-12-31 | 13G | ESSA Pharma Inc. EPIX |
BB Biotech AG | 7,879,583 17.900% |
2,863,769 (+57.09%) |
Filing History |